Virsik Peter's Insider Trades & SAST Disclosures
Virsik Peter's most recent trade in Essa Pharma Inc was a trade of 694 Common Shares done at an average price of $6.0 . Disclosure was reported to the exchange on Oct. 7, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Virsik Peter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.03 per share. | 07 Oct 2024 | 694 | 7,776 (0%) | 0% | 6.0 | 4,185 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 09 Sep 2024 | 694 | 8,470 (0%) | 0% | 6 | 4,164 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.03 per share. | 03 Sep 2024 | 2,082 | 9,164 (0%) | 0% | 6.0 | 12,554 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.95 per share. | 06 May 2024 | 694 | 11,246 (0%) | 0% | 6.9 | 4,823 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.94 per share. | 05 Apr 2024 | 694 | 11,940 (0%) | 0% | 7.9 | 5,510 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 110,000 | 110,000 | - | - | Options | |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.98 per share. | 05 Mar 2024 | 694 | 12,634 (0%) | 0% | 9.0 | 6,232 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 72,782 | 895,000 | - | - | Options | |
|
Essa Pharma Inc
|
Virsik Peter | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.29 per share. | 06 Feb 2024 | 72,782 | 13,328 (0%) | 1% | 10.3 | 748,927 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.23 per share. | 06 Feb 2024 | 72,782 | 86,110 (1%) | 1% | 3.2 | 235,086 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.25 per share. | 05 Feb 2024 | 694 | 13,328 (0%) | 0% | 9.3 | 6,420 | Common Shares |
|
Essa Pharma Inc
|
Virsik Peter | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.04 per share. | 05 Feb 2024 | 500 | 13,328 (0%) | 0% | 10.0 | 5,020 | Common Shares |
|
Essa Pharma Inc
|
Virsik Peter | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 500 | 967,782 | - | - | Options | |
|
Essa Pharma Inc
|
Virsik Peter | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.23 per share. | 05 Feb 2024 | 500 | 13,828 (0%) | 0% | 3.2 | 1,615 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.23 per share. | 16 Jan 2024 | 1,718 | 15,740 (0%) | 0% | 3.2 | 5,549 | Common Shares |
|
Essa Pharma Inc
|
Virsik Peter | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 1,718 | 968,282 | - | - | Options | |
|
Essa Pharma Inc
|
Virsik Peter | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 16 Jan 2024 | 1,718 | 14,022 (0%) | 0% | 10.0 | 17,197 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 05 Jan 2024 | 699 | 14,022 (0%) | 0% | 6.1 | 4,271 | Common Shares |
|
Essa Pharma Inc
|
Peter Virsik | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges